PHARMERICA CORP's ticker is PMC and the CUSIP is 71714F104. A total of 151 filers reported holding PHARMERICA CORP in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $300,000 | -58.4% | 11,428 | -62.9% | 0.01% | -60.0% |
| Q1 2017 | $721,000 | -71.6% | 30,800 | -69.5% | 0.02% | -69.4% |
| Q4 2016 | $2,541,000 | +21.6% | 101,050 | +35.7% | 0.05% | +32.4% |
| Q3 2016 | $2,090,000 | -23.6% | 74,450 | -32.9% | 0.04% | -35.1% |
| Q2 2016 | $2,734,000 | +36.9% | 110,880 | +22.8% | 0.06% | +35.7% |
| Q1 2016 | $1,997,000 | +27.1% | 90,310 | +19.1% | 0.04% | +55.6% |
| Q4 2014 | $1,571,000 | -7.3% | 75,847 | +9.3% | 0.03% | -3.6% |
| Q3 2014 | $1,695,000 | -25.9% | 69,387 | -13.3% | 0.03% | -26.3% |
| Q2 2014 | $2,287,000 | -20.7% | 79,999 | -22.4% | 0.04% | -20.8% |
| Q1 2014 | $2,883,000 | +73.4% | 103,029 | +33.2% | 0.05% | +92.0% |
| Q4 2013 | $1,663,000 | +256.1% | 77,329 | +119.7% | 0.02% | +212.5% |
| Q3 2013 | $467,000 | +35.8% | 35,200 | +41.9% | 0.01% | +33.3% |
| Q2 2013 | $344,000 | – | 24,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Smith, Graham & Co., Investment Advisors, LP | 372,169 | $8,229,000 | 1.08% |
| LOMBARDIA CAPITAL PARTNERS LLC | 839,636 | $18,564,000 | 0.96% |
| Malaga Cove Capital, LLC | 45,139 | $998,000 | 0.82% |
| Endurant Capital Management LP | 99,490 | $2,200,000 | 0.71% |
| Phocas Financial Corp. | 262,430 | $5,802,000 | 0.45% |
| Century Capital Management, LLC | 154,646 | $3,419,000 | 0.38% |
| Personal Capital Advisors Corp | 325,099 | $7,188,000 | 0.33% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 718,292 | $15,881,000 | 0.31% |
| ENDICOTT MANAGEMENT CO | 30,000 | $663,000 | 0.23% |
| Convergence Investment Partners, LLC | 70,550 | $1,560,000 | 0.19% |